Disseminated Monkeypox Infection in a Kidney Transplant Recipient: A Case Report

Transplant Proc. 2023 Apr;55(3):667-671. doi: 10.1016/j.transproceed.2023.02.031. Epub 2023 Mar 21.

Abstract

Monkeypox is a rapidly spreading infection worldwide and is a public health concern, especially with newly reported fatality cases. The characteristics and disease course of monkeypox infection in transplant recipients remain elusive because no case reports have been published detailing its clinical presentation and outcome in this population. We report a case of a kidney transplant recipient who developed end-stage renal disease secondary to HIV-associated nephropathy and manifested monkeypox infection after kidney transplantation. The patient had severe clinical manifestations, including disseminated vesicular skin rash, diffuse mucosal involvement, urine retention, proctitis, and bowel obstruction. We also highlight several clinical considerations regarding the use of tecovirimat, a novel antiviral therapy with activity against orthopoxviruses that has been used in the United States to treat monkeypox infection.

Publication types

  • Case Reports

MeSH terms

  • Antiviral Agents
  • Benzamides
  • Humans
  • Kidney Transplantation* / adverse effects
  • Mpox, Monkeypox*
  • Transplant Recipients

Substances

  • Antiviral Agents
  • Benzamides